Market Research Future published a research report on Non-Invasive Prenatal Testing (NIPT) Market Research Report – Global Forecast till 2025. Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.
Non-Invasive Prenatal Testing (NIPT) Market Overview
NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition. These devices and procedures are used for applications. As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births. The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.
The global NIPT market has been segmented based on product type, techniques, application, and end user.
The market, based on product type, has been divided into devices, consumables, and others. The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others. The devices are likely to hold the maximum market share in the global NIPT market. Consumables are further segmented into assay kits & reagents, disposables, and others.
The global NIPT market on the basis of techniques has been segregated into biochemical screening tests and ultrasound detection.
On the basis of application, the global non-invasive prenatal testing market is segmented into trisomy microdeletion syndrome and others.
The end user segment of the market consists of diagnostic laboratories, hospitals, and research institutes. The diagnostic laboratories segment is expected to hold the largest share of the market as these centers are primary locations for patients receiving non-invasive prenatal testing.
Some of the key players in the global NIPT market are Laboratory Corporation of America Holdings (US), Natera, Inc, Yourgene Health (UK), Centogene Holding AG [CENTOGENE AG ] (Germany), Agilent Technologies, Inc, Beijing Genomics Institute (China), General Electric Company [GE Healthcare] (US), Illumina, Inc, Perkinelmer, Inc, PhytoHealth Corporation (Taiwan), Tarsa Therapeutics, Inc, Thermo Fisher Scientific, Inc, and F Hoffman-La Roche Ltd.
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced NIPT procedures. The non-invasive prenatal testing market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.